Literature DB >> 17196446

Role of Claspin in regulation of nucleotide excision repair factor DDB2.

Mette Praetorius-Ibba1, Qi-En Wang, Gulzar Wani, Mohamed A El-Mahdy, Qianzheng Zhu, Song Qin, Altaf A Wani.   

Abstract

The replication checkpoint protein Claspin is important for maintenance of genomic stability and is required for cells to overcome genotoxic stress. Upon UV-induced DNA damage, Claspin is required for activation of the ATR-mediated DNA damage checkpoint response, leading to arrest of DNA replication and inhibition of cell cycle progression. Located at the DNA replication fork, Claspin is also suggested to monitor replication and sense damage. Our present studies in HeLa cells demonstrate associations between the Claspin/ATR-related DNA damage checkpoint response and the global genomic nucleotide excision repair pathway. siRNA-mediated knockdown of Claspin abolishes the UV-induced degradation of DDB2 and impairs the co-localization of DDB2 to DNA damage sites. Thus, the presence of Claspin is required for the total turnover of DNA damage binding protein DDB2, as well as for its functionality in DNA damage recognition. Claspin, however, seems not to be required for maintaining the cellular level of the NER factor XPC and its UV-induced post-translational modifications. Co-localization of XPC with DNA lesions is also intact in the absence of Claspin as is the repair of the UV-induced lesions CPD and 6-4PP. Claspin itself may be directly responsible for physical interaction between the two pathways since Claspin is able to associate with DDB1, DDB2 and XPC. Taken together, these findings reveal physical and functional interplay between Claspin and NER-related proteins and demonstrate crosstalk between the DNA damage checkpoint control and DNA damage repair pathways.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17196446     DOI: 10.1016/j.dnarep.2006.11.009

Source DB:  PubMed          Journal:  DNA Repair (Amst)        ISSN: 1568-7856


  8 in total

1.  DDB2 increases radioresistance of NSCLC cells by enhancing DNA damage responses.

Authors:  Ning Zou; Guozhen Xie; Tiantian Cui; Amit Kumar Srivastava; Meihua Qu; Linlin Yang; Shaozhong Wei; Yanfang Zheng; Qi-En Wang
Journal:  Tumour Biol       Date:  2016-08-23

2.  Cellular concentrations of DDB2 regulate dynamic binding of DDB1 at UV-induced DNA damage.

Authors:  Sergey Alekseev; Martijn S Luijsterburg; Alex Pines; Bart Geverts; Pierre-Olivier Mari; Giuseppina Giglia-Mari; Hannes Lans; Adriaan B Houtsmuller; Leon H F Mullenders; Jan H J Hoeijmakers; Wim Vermeulen
Journal:  Mol Cell Biol       Date:  2008-10-20       Impact factor: 4.272

3.  ATR kinase is required for global genomic nucleotide excision repair exclusively during S phase in human cells.

Authors:  Yannick Auclair; Raphael Rouget; El Bachir Affar; Elliot A Drobetsky
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-11       Impact factor: 11.205

4.  Molecular and genomic approach for understanding the gene-environment interaction between Nrf2 deficiency and carcinogenic nickel-induced DNA damage.

Authors:  Hye Lim Kim; Young Rok Seo
Journal:  Oncol Rep       Date:  2012-09-26       Impact factor: 3.906

Review 5.  Mind the gap: keeping UV lesions in check.

Authors:  Daniele Novarina; Flavio Amara; Federico Lazzaro; Paolo Plevani; Marco Muzi-Falconi
Journal:  DNA Repair (Amst)       Date:  2011-05-23

Review 6.  Circadian Rhythm of NER and ATR Pathways.

Authors:  Tae-Hong Kang
Journal:  Biomolecules       Date:  2021-05-11

7.  Regulation and role of Arabidopsis CUL4-DDB1A-DDB2 in maintaining genome integrity upon UV stress.

Authors:  Jean Molinier; Esther Lechner; Eva Dumbliauskas; Pascal Genschik
Journal:  PLoS Genet       Date:  2008-06-13       Impact factor: 5.917

8.  USP13 regulates the RAP80-BRCA1 complex dependent DNA damage response.

Authors:  Yunhui Li; Kuntian Luo; Yujiao Yin; Chenming Wu; Min Deng; Lei Li; Yuping Chen; Somaira Nowsheen; Zhenkun Lou; Jian Yuan
Journal:  Nat Commun       Date:  2017-06-01       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.